SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 52 filers reported holding SAGE THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $6,018,560 | -7.5% | 128,000 | -17.4% | 0.94% | -13.5% |
| Q1 2023 | $6,503,800 | +778.9% | 155,000 | +1712.0% | 1.09% | +1547.0% |
| Q4 2020 | $740,000 | -94.0% | 8,554 | -93.3% | 0.07% | -95.2% |
| Q4 2018 | $12,261,000 | +44.7% | 128,000 | +113.3% | 1.38% | +42.0% |
| Q3 2018 | $8,475,000 | +58.8% | 60,000 | +85.2% | 0.97% | +55.4% |
| Q4 2017 | $5,336,000 | +904.9% | 32,400 | +280.4% | 0.63% | +734.7% |
| Q3 2017 | $531,000 | +33.4% | 8,518 | +70.4% | 0.08% | +10.3% |
| Q2 2017 | $398,000 | -88.8% | 5,000 | -90.0% | 0.07% | -90.2% |
| Q1 2017 | $3,554,000 | -22.7% | 50,000 | -44.4% | 0.70% | -40.2% |
| Q4 2016 | $4,595,000 | -37.4% | 90,000 | -43.6% | 1.16% | -2.8% |
| Q3 2016 | $7,345,000 | +250.8% | 159,500 | +129.5% | 1.20% | +119.9% |
| Q2 2016 | $2,094,000 | -46.9% | 69,500 | -43.5% | 0.54% | -36.4% |
| Q1 2016 | $3,943,000 | -27.3% | 123,000 | +32.3% | 0.86% | +7.7% |
| Q4 2015 | $5,422,000 | +1499.4% | 93,000 | +1062.5% | 0.79% | +1746.5% |
| Q3 2015 | $339,000 | -90.3% | 8,000 | -83.3% | 0.04% | -87.5% |
| Q2 2015 | $3,504,000 | +6.1% | 48,000 | -27.0% | 0.34% | -0.3% |
| Q1 2015 | $3,301,000 | +13.1% | 65,724 | -17.6% | 0.34% | -30.8% |
| Q4 2014 | $2,918,000 | +5.3% | 79,724 | -9.3% | 0.50% | +45.3% |
| Q3 2014 | $2,770,000 | – | 87,924 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,966,688 | $120,204,000 | 10.81% |
| Integral Health Asset Management, LLC | 230,000 | $14,058,000 | 4.30% |
| Asymmetry Capital Management, L.P. | 102,462 | $6,262,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 225,000 | $13,752,000 | 3.74% |
| DAFNA Capital Management LLC | 158,306 | $9,676,000 | 3.14% |
| Bain Capital Life Sciences Investors, LLC | 499,100 | $30,505,000 | 2.84% |
| Boxer Capital, LLC | 1,094,000 | $66,865,000 | 2.31% |
| Palo Alto Investors LP | 590,200 | $36,073,000 | 1.98% |
| Logos Global Management LP | 250,000 | $15,280,000 | 1.96% |
| Bellevue Group AG | 1,579,504 | $96,539,000 | 1.33% |